openPR Logo
Press release

Liquid Biopsy Market - Detailed Analysis of Current Industry Figures with Forecasts Growth By 2023

01-20-2020 03:00 PM CET | Associations & Organizations

Press release from: Liquid Biopsy Market

Liquid Biopsy Market - Detailed Analysis of Current Industry

The global liquid biopsy market should reach $6.1 billion by 2023 from $2.4 billion in 2018 at a compound annual growth rate (CAGR) of 20.8% for the period 2018 to 2023.

Report Scope:

The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents, and companies. The market sizes for liquid biopsy diagnostics are given for 2017, 2018 and 2023 (forecasted).

Request For Report Sample: https://www.trendsmarketresearch.com/report/sample/11626

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. The report then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Key forces driving the market are enumerated.

The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2017 through November 2018. Industry subsectors analyzed include advanced sequencing instruments; droplet digital PCR (polymerase chain reaction); target enrichment; single-cell DNA polymerase; non-invasive prenatal testing (NIPT); fetal-cell NIPT; CTC (circulating tumor cell) capture and detection; and liquid biopsy.

The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics, and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring), and geography (North America, Europe, Asia/Pacific, Rest of World).

Market data covers 2017, 2018 and 2023 (forecasted).

More than 175 companies in the liquid biopsy industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from January 2017 through November 2018, including key alliance trends.

Early buyers will get up to 20% Discount on this report@: https://www.trendsmarketresearch.com/report/discount/11626

Report Includes:

- 32 data tables and 54 additional tables
- Industry analysis of the liquid biopsy biomarkers and technologies market
- Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Characterization and quantification of market potential for liquid biopsy diagnostics by application, biomarker type, analysis platform, analysis purpose and geographical region
- Discussion of several significant large-scale research initiatives that are contributing to liquid biopsy market development
- Examination of various conventional biopsy methods and highlight how liquid biopsy enabling technologies address the issues and are gaining significant traction with key opinion leaders
- Coverage of significant patents and their allotments in each category, as well as major industry acquisitions and strategic alliances data
- Company profiles of major manufacturers and suppliers of liquid biopsy research tools, services and diagnostics, including Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, Qiagen, Quantum Biosystems, Roche and Thermo Fisher Scientific

Summary

Liquid biopsy is an attractive option as a supplement or alternative to doing a tissue biopsy for applications in reproductive health, cancer and transplant medicine. Liquid biopsy involves detecting and analyzing “foreign”-derived biomarkers present in body fluids such as blood or urine. The origin of the biomarker defines the liquid biopsy application: tumor (cancer applications); fetus (prenatal screening applications); or transplanted organ (transplant medicine applications).

Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable detection of biomarkers that are present in fluids at very low concentrations.

Buy Full Report Now @ https://www.trendsmarketresearch.com/checkout/11626/Single

Competitors clusters around each of the three applications segments — non-invasive prenatal screening (NIPT), cancer and transplant medicine — although there is recent movement across the segments by some companies.

When compared with conventional tissue biopsy, liquid biopsy tests address a significant medical need: a biopsy that is non-invasive and has little or no risk of medical complications. The validation of this testing platform and demonstration of clinical utility first occurred in the high-risk pregnancy segment of the NIPT industry, resulting in high market penetration. Substantial progress is being made in the average-risk pregnancy NIPT market segment and in some applications in cancer and transplant medicine.

Contact Us:
One Vincent Square
Westminster, London SW1P 2PN
United Kingdom
Email: sales@trendsmarketresearch.com
Website: https://www.trendsmarketresearch.com

About Us:
We are a UK-based market intelligence company that operates out of its passion to help brands grow, discover, and transform. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liquid Biopsy Market - Detailed Analysis of Current Industry Figures with Forecasts Growth By 2023 here

News-ID: 1901571 • Views: 238

More Releases from Liquid Biopsy Market

Liquid Biopsy Market Business Opportunities to 2025 Reviewed in New Report
Liquid biopsy is a non-invasive technology that identifies molecular biomarkers using liquid sample instead of using costly or invasive procedures. These tests have great potential for primary detection of cancer, treatment and recurrence monitoring, recognition of genetic abnormalities in foetus, and graft rejection in transplantation patients. Demand Scenario The global liquid biopsy market was USD 1074.73 million in 2018 and is estimated to reach USD 2832.96 million by 2025 at a CAGR
Liquid Biopsy Market With Leading Major Players – Roche Diagnostics, Biocept I …
Researchmoz added Most up-to-date research on "Liquid Biopsy Market, Global Analysis by Cancer (Lung, Breast, Colorectal, etc), Products, Circulating Biomarkers, Sample, Clinical Application, Regions & Companies" to its huge collection of research reports. The Liquid Biopsy market report [8 Year Forecast 2018-2026] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info.
Liquid Biopsy Market size set to grow according to Forecast 2019 – 2024 (Full …
Researchmoz added Most up-to-date research on "Liquid Biopsy Market, Global Analysis by Cancer (Lung, Breast, Colorectal, etc), Products, Circulating Biomarkers, Sample, Clinical Application, Regions & Companies" to its huge collection of research reports. Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has
Global Liquid Biopsy Market to 2026| Biocept, Inc., MDxHealth, Myriad Genetics, …
Researchmoz added Most up-to-date research on "Liquid Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026" to its huge collection of research reports. This report on the global liquid biopsy market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary

All 5 Releases


More Releases for Industry

Global Bisphenol A Industry
Global Bisphenol A market size is accounted for $14.6 billion in 2014 and is expected to grow at a CAGR of 5.2% to reach $21.9 billion by 2022. The drivers of the market are raising demand for polycarbonate plastics and epoxy resins, growth in global automobile sector and rapid growth in demand for Bisphenol A in developing countries. The challenges faced by the market are volatility in crude oil prices
Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medic …
Researchmoz added Most up-to-date research on "Global Nutraceuticals Market By Application | Food Industry, Ink Industry, Medicine Industry, Electronic Industry and Paint Industry" to its huge collection of research reports. This report studies Nutraceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers
Global Email Marketing Industry
Albany, New York, May 10, 2017: The increasing number of internet users and the rising of the retail/e-commerce industry across the globe is likely to boost the demand for email marketing over the next few years. This rapidly rising global email marketing industry is the focus of a new market report recently added to the massive online repository of Market Research Reports Search Engine (MRRSE) with a title of “Email
Digital Transformation / “Industry 4.0”
Wesseling, April 12th 2017: When humans, machines and industrial processes are intelligently connected then we are speaking about “Industry 4.0”. Thus it is possible to create and provide customised products and services whereat most modern information and communication technologies are used. Intelligent, digital and flexible cross-linked systems and production processes form the technical basis for well- and efficiently-designed processes. UIM is working within the digital transformation section today and acquired
2016 Connector Industry Yearbook
ReportsWorldwide has announced the addition of a new report title 2016 Connector Industry Yearbook to its growing collection of premium market research reports. Each year, Bishop & Associates prepares the Connector Industry Yearbook based on annual reports provided by publicly traded connector companies. Income statements and balance sheets are consolidated for the past 10 years, 5 years, and most current year, providing benchmarks on the industry and the overall performance
BMR Industry
Notes: Sales, means the sales volume of Embedded Analytics Revenue, means the sales value of Embedded Analytics Get Sample Copy of Report: https://goo.gl/OUc8J0 This report studies sales (consumption) of Embedded Analytics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Microsoft Corporation IBM Corporation SAP SE Opentext Corporation Microstrategy, Inc. Logi Analytics, Inc. Sisense, Inc. Birst, Inc. Information Builders Tibco Software, Inc. Qlik